BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34965957)

  • 1. Yet another amyloidosis.
    Means RT
    J Investig Med; 2022 Feb; 70(2):347. PubMed ID: 34965957
    [No Abstract]   [Full Text] [Related]  

  • 2. Unfolding Cardiac Amyloidosis -From Pathophysiology to Cure.
    Ablasser K; Verheyen N; Glantschnig T; Agnetti G; Rainer PP
    Curr Med Chem; 2019; 26(16):2865-2878. PubMed ID: 29303069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding and recognizing cardiac amyloidosis.
    McVeigh T; Tennyson C
    JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends and causes of hospitalizations in patients with amyloidosis.
    Patil N; Arora S; Qamar A; Strassle PD; Alexander KM; Fatima A; Maurer MS; Grodin JL; Pandey A
    Amyloid; 2019 Sep; 26(3):177-178. PubMed ID: 31172802
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel Cardiovascular Magnetic Resonance Model to Distinguish Immunoglobulin Light Chain From Transthyretin Cardiac Amyloidosis.
    Slivnick JA; Tong MS; Nagaraja HN; Elamin MB; Wallner A; O'Brien A; Raman SV; Zareba KM
    JACC Cardiovasc Imaging; 2021 Jan; 14(1):302-304. PubMed ID: 32950451
    [No Abstract]   [Full Text] [Related]  

  • 6. The Ultrastructure of Tissue Damage by Amyloid Fibrils.
    Koike H; Katsuno M
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once AL amyloidosis: not always AL amyloidosis.
    Jhaveri T; Sarosiek S; Ruberg FL; Siddiqi O; Berk JL; Sanchorawala V
    Amyloid; 2018 Jun; 25(2):139-140. PubMed ID: 29516761
    [No Abstract]   [Full Text] [Related]  

  • 8. Sporadic transthyretin amyloidosis with a novel TTR gene mutation misdiagnosed as primary amyloidosis.
    Briani C; Cavallaro T; Ferrari S; Taioli F; Calamelli S; Verga L; Adami F; Fabrizi GM
    J Neurol; 2012 Oct; 259(10):2226-8. PubMed ID: 22580845
    [No Abstract]   [Full Text] [Related]  

  • 9. CMR and amyloid cardiomyopathy: are we getting closer to the biology?
    Kwong RY; Jerosch-Herold M
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):166-8. PubMed ID: 24524743
    [No Abstract]   [Full Text] [Related]  

  • 10. Emerging treatments for amyloidosis.
    Sayed RH; Hawkins PN; Lachmann HJ
    Kidney Int; 2015 Mar; 87(3):516-26. PubMed ID: 25469850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathy Associated with Systemic Amyloidosis.
    Kaku M; Berk JL
    Semin Neurol; 2019 Oct; 39(5):578-588. PubMed ID: 31639841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics.
    Vrana JA; Theis JD; Dasari S; Mereuta OM; Dispenzieri A; Zeldenrust SR; Gertz MA; Kurtin PJ; Grogg KL; Dogan A
    Haematologica; 2014 Jul; 99(7):1239-47. PubMed ID: 24747948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac amyloidosis.
    Quarta CC; Kruger JL; Falk RH
    Circulation; 2012 Sep; 126(12):e178-82. PubMed ID: 22988049
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac Amyloidosis: Diagnosis and Treatment Strategies.
    Tuzovic M; Yang EH; Baas AS; Depasquale EC; Deng MC; Cruz D; Vorobiof G
    Curr Oncol Rep; 2017 Jul; 19(7):46. PubMed ID: 28528458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage.
    Izumiya Y; Hayashi H; Ishikawa H; Shibata A; Yoshiyama M
    Intern Med; 2021 Jan; 60(1):1-7. PubMed ID: 32713926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological review of cardiac amyloidosis using autopsy cases in a single Japanese institution.
    Tateishi Y; Yamada Y; Katsuki M; Nagata T; Yamamoto H; Kohashi K; Koga Y; Hashisako M; Kiyozawa D; Mori T; Kuboyama Y; Kakinokizono A; Miyazaki Y; Yamaguchi A; Tsutsui H; Ninomiya T; Naiki H; Oda Y
    Pathol Res Pract; 2021 Nov; 227():153635. PubMed ID: 34653913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of light-chain and transthyretin-related categories in cardiac amyloidosis: A systematic review and meta-analysis.
    Xin Y; Hu W; Chen X; Hu J; Sun Y; Zhao Y
    Hellenic J Cardiol; 2019; 60(6):375-383. PubMed ID: 30742933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Phase
    Galat A; Van der Gucht A; Guellich A; Bodez D; Cottereau AS; Guendouz S; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T; Rosso J
    JACC Cardiovasc Imaging; 2017 May; 10(5):601-603. PubMed ID: 27424245
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular Mechanisms of Cardiac Amyloidosis.
    Saito Y; Nakamura K; Ito H
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.